11:30 am–12:30 pm Saturday, September 7

It's Time to Expect More: Developing Leadership Skills at all Levels (227)

Leadership in pediatric hematology-oncology nursing can be found in many capacities. Nurses are leaders at the bedside, in a charge nurse role, in evidence-based practice and other unit-based projects, in provider roles, in manager and director roles, etc. Nurses in this field tend to be motivated to move the profession forward, and it is important that those who aspire to “lead” in any of these roles be given the tools to be successful.

Read more...
11:30 am–12:30 pm Saturday, September 7

Creating the Spark - Inspire Learning with Interactive Activities for the Chemotherapy/Biotherapy Provider Course (226)

The 4th edition of the APHON Chemotherapy and Biotherapy Curriculum was published earlier this year. Extensive updates to the 4th edition book and live instructor course created a need to provide ongoing support for the 550 instructors as they familiarize themselves with the updated content and revised lectures. Central to the updated material is a focus on interactive teaching strategies.

Read more...
11:30 am–12:30 pm Saturday, September 7

The Autoimmune Cytopenias: Deactivating the Self-Destruct Sequence (225)

Autoimmune cytopenias include autoimmune hemolytic anemia (AIHA), immune thrombocytopenia (ITP), autoimmune neutropenia (AIN), and Evan’s syndrome (ES). This diverse group of hematologic disorders is characterized by the production of autoantibodies by the patient’s own immune system against hematopoietic cells in the blood or bone marrow.

Read more...
Speaker:
Karyn Brundige, MSN CPNP
CNE Hours
1
RX Hours
0.17
11:30 am–12:30 pm Saturday, September 7

Diagnostic Dilemmas in Pediatric Oncology Patients with Rare Neurological Complications: A Complex Case Series Review (224)

Advanced Care Providers (ACPs) are experts at treating common conditions that children with cancer experience; however, unusual clinical presentations can create a diagnostic dilemma with subsequent difficulty in management. When a challenging diagnostic case is faced in clinical practice, or when a patient does not respond to first-line interventions for a complication, the ACP must be equipped to identify differential diagnoses and understand the appropriate evaluations. This presentation will review four children with cancer who had atypical neurologic complications or manifestations.

Read more...
4:15–5:15 pm Friday, September 6

Immune-Mediated Thrombocytopenia: An Overview (221)

Immune-mediated thrombocytopenia, or “ITP,” is one of the most common causes of symptomatic thrombocytopenia in children and adolescents. Clinical presentation and course, epidemiology, diagnostic modalities and criteria, treatment options, and long-term sequelae will be reviewed with attention to the nurse/advanced practice nurse who desires a comprehensive overview of the subject. Case studies will be utilized to highlight the frequent clinical variance of the condition. Read more...
4:15–5:15 pm Friday, September 6

CLABSIs in Pediatric Hem/Onc/BMT Patients – Why Aren’t We at Zero, and Will We Ever Get There? (220)

Central line-associated bloodstream infections (CLABSIs) continue to be an important source of morbidity for children with cancer and those undergoing hematopoietic stem cell transplant. As many institutions strive to achieve rates of zero, nurses need to be aware of distinct challenges involving the pediatric hematology/oncology/transplant population.

Read more...
Speaker:
Lauri Linder, PhD APRN CPON®
CNE Hours
1
4:15–5:15 pm Friday, September 6

2nd Victims in Health Care: What does it mean and how is it affecting Nurses (219)

In an era of healthcare transformation, where transparency and high reliability are paramount concepts, the ideal healthcare providers are always held to is “do no harm.” Nurses continue to be the most trusted professionals and are held to very high standards, and with this comes the risk or consequence of losing that trust with any lapse in judgment, miss in critical thinking, or plainly being overworked or overwhelmed. In this session, we will look to explore the concept of the 2nd victim, which is when healthcare workers are involved in an adverse patient event and subsequently are traumatized by the event.

Read more...
4:15–5:15 pm Friday, September 6

Advances in Pediatric Neuro-Oncology in the Molecular Era (218)

Pediatric CNS tumors as a group represent the most common solid tumor in childhood and encompass a wide variety of diagnoses, from benign to malignant. Recent advances in molecular profiling have led to significant changes in the classification of pediatric CNS tumors, with a positive impact on diagnosis, prognosis, and treatment. Gliomas have undergone reclassification with emphasis on molecular profile over histology, leading to a redefinition of traditional low-grade versus high-grade glioma.

Read more...
Speaker:
Cheryl Fischer, MSN RN CPNP
CNE Hours
1
11:30 am–12:30 pm Friday, September 6

High Dollar Medications and Therapies: Challenges for our Families and Challenges for Us! (215)

Treatment options for children with cancer continue to grow and bring exciting opportunities for a cure in situations where there was previously no hope. Some therapies come at a very high cost. At the same time, the cost of health care in the United States continues to grow. The complexity of healthcare reimbursement includes varied payment options, including governmental programs; commercial insurance, which can range from excellent coverage to a high deductible plan; and sometimes nontraditional methods of payment, such as shared ministry programs or “self-pay.”

Read more...
Speaker:
Kaye Schmidt, MA RN NEA-BC CPHON®
CNE Hours
1
Subscribe to this RSS feed